Logo image of LITS

LITE STRATEGY INC (LITS) Stock Fundamental Analysis

USA - NASDAQ:LITS - US55279B3015 - Common Stock

2.26 USD
+0.16 (+7.62%)
Last: 11/10/2025, 8:03:23 PM
2.2571 USD
0 (-0.13%)
After Hours: 11/10/2025, 8:03:23 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LITS. LITS was compared to 531 industry peers in the Biotechnology industry. LITS has a great financial health rating, but its profitability evaluates not so good. LITS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LITS had negative earnings in the past year.
In the past year LITS has reported a negative cash flow from operations.
LITS had negative earnings in 4 of the past 5 years.
LITS had a negative operating cash flow in each of the past 5 years.
LITS Yearly Net Income VS EBIT VS OCF VS FCFLITS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -87.20%, LITS is doing worse than 72.13% of the companies in the same industry.
LITS has a Return On Equity (-94.18%) which is in line with its industry peers.
Industry RankSector Rank
ROA -87.2%
ROE -94.18%
ROIC N/A
ROA(3y)-23.53%
ROA(5y)-24.99%
ROE(3y)-56.59%
ROE(5y)-71.43%
ROIC(3y)N/A
ROIC(5y)N/A
LITS Yearly ROA, ROE, ROICLITS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LITS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LITS Yearly Profit, Operating, Gross MarginsLITS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

More info and screens

7

2. Health

2.1 Basic Checks

LITS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LITS has about the same amount of shares outstanding.
LITS has more shares outstanding than it did 5 years ago.
LITS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LITS Yearly Shares OutstandingLITS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
LITS Yearly Total Debt VS Total AssetsLITS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

LITS has an Altman-Z score of 0.20. This is a bad value and indicates that LITS is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 0.20, LITS is doing good in the industry, outperforming 60.83% of the companies in the same industry.
LITS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.2
ROIC/WACCN/A
WACC8.75%
LITS Yearly LT Debt VS Equity VS FCFLITS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

2.3 Liquidity

LITS has a Current Ratio of 13.50. This indicates that LITS is financially healthy and has no problem in meeting its short term obligations.
LITS has a Current ratio of 13.50. This is amongst the best in the industry. LITS outperforms 89.08% of its industry peers.
LITS has a Quick Ratio of 13.50. This indicates that LITS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 13.50, LITS belongs to the best of the industry, outperforming 89.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.5
Quick Ratio 13.5
LITS Yearly Current Assets VS Current LiabilitesLITS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

LITS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -189.72%.
Looking at the last year, LITS shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)-189.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.4%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, LITS will show a very strong growth in Earnings Per Share. The EPS will grow by 32.35% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y40.92%
EPS Next 2Y32.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LITS Yearly Revenue VS EstimatesLITS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 20M 40M 60M
LITS Yearly EPS VS EstimatesLITS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LITS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LITS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LITS Price Earnings VS Forward Price EarningsLITS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LITS Per share dataLITS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

A more expensive valuation may be justified as LITS's earnings are expected to grow with 32.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.35%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LITS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LITE STRATEGY INC

NASDAQ:LITS (11/10/2025, 8:03:23 PM)

After market: 2.2571 0 (-0.13%)

2.26

+0.16 (+7.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-26 2025-09-26/amc
Earnings (Next)11-10 2025-11-10
Inst Owners8.13%
Inst Owner ChangeN/A
Ins Owners14.43%
Ins Owner Change55.87%
Market Cap80.59M
Revenue(TTM)N/A
Net Income(TTM)-15.95M
Analysts43.33
Price TargetN/A
Short Float %1.11%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.76
P/tB 4.76
EV/EBITDA N/A
EPS(TTM)-2.39
EYN/A
EPS(NY)-3.78
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.58
OCFYN/A
SpS0
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -87.2%
ROE -94.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-23.53%
ROA(5y)-24.99%
ROE(3y)-56.59%
ROE(5y)-71.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.5
Quick Ratio 13.5
Altman-Z 0.2
F-Score2
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)4.03%
Cap/Depr(5y)80.47%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-189.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.4%
EPS Next Y40.92%
EPS Next 2Y32.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-168.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.7%
OCF growth 3YN/A
OCF growth 5YN/A

LITE STRATEGY INC / LITS FAQ

What is the ChartMill fundamental rating of LITE STRATEGY INC (LITS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to LITS.


What is the valuation status for LITS stock?

ChartMill assigns a valuation rating of 1 / 10 to LITE STRATEGY INC (LITS). This can be considered as Overvalued.


Can you provide the profitability details for LITE STRATEGY INC?

LITE STRATEGY INC (LITS) has a profitability rating of 0 / 10.


Can you provide the financial health for LITS stock?

The financial health rating of LITE STRATEGY INC (LITS) is 7 / 10.


Can you provide the expected EPS growth for LITS stock?

The Earnings per Share (EPS) of LITE STRATEGY INC (LITS) is expected to grow by 40.92% in the next year.